Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

108.24
+1.191.11%
Post-market: 108.240.00000.00%18:16 EDT
Volume:601.59K
Turnover:65.25M
Market Cap:6.55B
PE:14.41
High:109.43
Open:106.94
Low:106.56
Close:107.05
Loading ...

Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (Zanidatamab-Hrii) in First-Line Her2-Positive Metastatic Gastroesophageal Adenocarcinoma at Asco 2025

THOMSON REUTERS
·
03 Jun

Spanish stocks - Factors to watch on June 2

Reuters
·
02 Jun

Jazz Pharmaceuticals Unveils Promising Phase 4 Research Results for Xywav® in Treating Sleep Disorders at SLEEP 2025

Reuters
·
29 May

Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Vaxcyte (PCVX) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
23 May

Jazz Pharmaceuticals plc to Participate in Jefferies Global Healthcare Conference

Reuters
·
22 May

Seamus Mulligan, Director, Reports Acquisition of Common Shares in Jazz Pharmaceuticals plc

Reuters
·
14 May

Jazz Pharmaceuticals Plc : Morgan Stanley Cuts Target Price to $166.00 From $183.00

THOMSON REUTERS
·
08 May

Stock Track | Jazz Pharmaceuticals Plummets 5.85% as Multiple Analysts Cut Target Prices

Stock Track
·
07 May

Jazz Pharmaceuticals Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
07 May

Jazz Pharmaceuticals Price Target Maintained With a $200.00/Share by Needham

Dow Jones
·
07 May

Morgan Stanley Cuts Price Target on Jazz Pharmaceuticals to $166 From $183, Keeps Overweight Rating

MT Newswires Live
·
07 May

Jazz Pharmaceuticals Plc : Bofa Global Research Raises Price Objective to $216 From $213

THOMSON REUTERS
·
07 May

Jazz Pharmaceuticals Plc : RBC Cuts Target Price to $172 From $182

THOMSON REUTERS
·
07 May

Jazz Q1 Earnings, Revenue Decline; Updates Outlook

MT Newswires Live
·
07 May

Jazz Pharmaceuticals PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Stock Track | Jazz Pharmaceuticals Plunges 6.89% After Hours on Disappointing Q1 2025 Earnings

Stock Track
·
07 May

Jazz Pharmaceuticals Q1 Adj. EPS $1.68 Misses $4.66 Estimate, Sales $897.84M Miss $985.39M Estimate

Benzinga
·
07 May

Stock Track | Jazz Pharmaceuticals Plunges 6.16% as Q1 Earnings Fall Short of Estimates

Stock Track
·
07 May

Stock Track | Jazz Pharmaceuticals Plummets 6.16% as Q1 Earnings Fall Short of Estimates

Stock Track
·
07 May

BRIEF-Jazz Pharmaceuticals Q1 Adjusted EPS USD 1.68 Vs. IBES Estimate USD 4.66

Reuters
·
07 May